Affordable Access

deepdyve-link
Publisher Website

SARS-CoV-2 testing and outcomes in the first 30 days after the first case of COVID-19 at an Australian children's hospital.

Authors
  • Ibrahim, Laila F1, 2, 3, 4
  • Tosif, Shidan1, 2, 3
  • McNab, Sarah1, 2, 3
  • Hall, Samantha1, 2
  • Lee, Hyun Jung5, 6
  • Lewena, Stuart1, 5, 7
  • Daley, Andrew J1, 8
  • Crawford, Nigel W1, 2, 3
  • Steer, Andrew C1, 2, 9
  • Bryant, Penelope A1, 2, 3, 4, 9
  • Babl, Franz E1, 5, 7
  • 1 Department of Paediatrics, The University of Melbourne, Melbourne, Victoria, Australia. , (Australia)
  • 2 Infection and Immunity, Murdoch Children's Research Institute, Melbourne, Victoria, Australia. , (Australia)
  • 3 Department of General Medicine, The Royal Children's Hospital, Melbourne, Victoria, Australia. , (Australia)
  • 4 Hospital-In-The-Home Department, The Royal Children's Hospital, Melbourne, Victoria, Australia. , (Australia)
  • 5 Emergency Research, Clinical Sciences, Murdoch Children's Research Institute, Melbourne, Victoria, Australia. , (Australia)
  • 6 Emergency Department, Soonchunhyang University Cheonan Hospital, Cheonan, Republic of Korea. , (North Korea)
  • 7 Emergency Department, The Royal Children's Hospital, Melbourne, Victoria, Australia. , (Australia)
  • 8 Department of Microbiology, The Royal Children's Hospital, Melbourne, Victoria, Australia. , (Australia)
  • 9 Infectious Diseases Unit, Department of General Medicine, The Royal Children's Hospital, Melbourne, Victoria, Australia. , (Australia)
Type
Published Article
Journal
Emergency medicine Australasia : EMA
Publication Date
Oct 01, 2020
Volume
32
Issue
5
Pages
801–808
Identifiers
DOI: 10.1111/1742-6723.13550
PMID: 32390285
Source
Medline
Keywords
Language
English
License
Unknown

Abstract

International studies describing COVID-19 in children have shown low proportions of paediatric cases and generally a mild clinical course. We aimed to present early data on children tested for SARS-CoV-2 at a large Australian tertiary children's hospital according to the state health department guidelines, which varied over time. We conducted a retrospective cohort study at The Royal Children's Hospital, Melbourne, Australia. It included all paediatric patients (aged 0-18 years) who presented to the ED or the Respiratory Infection Clinic (RIC) and were tested for SARS-CoV-2. The 30-day study period commenced after the first confirmed positive case was detected at the hospital on 21 March 2020, until 19 April 2020. We recorded epidemiological and clinical data. There were 433 patients in whom SARS-CoV-2 testing was performed in ED (331 [76%]) or RIC (102 [24%]). There were four (0.9%) who had positive SARS-CoV-2 detected, none of whom were admitted to hospital or developed severe disease. Of these SARS-CoV-2 positive patients, 1/4 (25%) had a comorbidity, which was asthma. Of the SARS-CoV-2 negative patients, 196/429 (46%) had comorbidities. Risk factors for COVID-19 were identified in 4/4 SARS-CoV-2 positive patients and 47/429 (11%) SARS-CoV-2 negative patients. Our study identified a very low rate of SARS-CoV-2 positive cases in children presenting to a tertiary ED or RIC, none of whom were admitted to hospital. A high proportion of patients who were SARS-CoV-2 negative had comorbidities. © 2020 Australasian College for Emergency Medicine.

Report this publication

Statistics

Seen <100 times